Distribution of insulin in trigeminal nerve and brain after intranasal administration

Scientific Reports

Volumn 9, Issue 1, 2019, Pages

  Lochhead, Jeffrey J ^a   Kellohen, Kathryn L ^a   Ronaldson, Patrick T ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; INSULIN; INSULIN RECEPTOR; PHOSPHOTYROSINE;

ANIMAL; BRAIN; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; METABOLISM; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; TRIGEMINAL NERVE; VASCULARIZATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; INSULIN; PHOSPHOTYROSINE; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; TISSUE DISTRIBUTION; TRIGEMINAL NERVE;

EID: 85062011658     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-39191-5     Document Type: Article

References (51)

1. Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 14, 168–181, 10.1038/nrneurol.2017.185 (2018).
2. Athauda, D. & Foltynie, T. Insulin resistance and Parkinson’s disease: A new target for disease modification? Prog Neurobiol 145–146, 98–120, 10.1016/j.pneurobio.2016.10.001 (2016).
3. Dodd, G. T. & Tiganis, T. Insulin action in the brain: Roles in energy and glucose homeostasis. J Neuroendocrinol 29, https://doi.org/10.1111/jne.12513 (2017).
4. Heni, M., Kullmann, S., Preissl, H., Fritsche, A. & Haring, H. U. Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11, 701–711, 10.1038/nrendo.2015.173 (2015).
5. Ghasemi, R. et al. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol 47, 1045–1065, 10.1007/s12035-013-8404-z (2013).
6. Ramalingam, M. & Kim, S. J. Mechanisms of action of brain insulin against neurodegenerative diseases. J Neural Transm (Vienna) 121, 611–626, 10.1007/s00702-013-1147-1 (2014).
7. Brabazon, F. et al. Intranasal insulin treatment of an experimental model of moderate traumatic brain injury. J Cereb Blood Flow Metab 37, 3203–3218, 10.1177/0271678X16685106 (2017).
8. Cholerton, B., Baker, L. D. & Craft, S. Insulin, cognition, and dementia. Eur J Pharmacol 719, 170–179, 10.1016/j.ejphar.2013.08.008 (2013).
9. Lioutas, V. A. et al. Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res 6, 264–275, 10.1007/s12975-015-0409-7 (2015).
10. Pang, Y. et al. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience 318, 157–165, 10.1016/j.neuroscience.2016.01.020 (2016).
11. Mao, Y. F. et al. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice. Aging Cell 15, 893–902, 10.1111/acel.12498 (2016).
12. Freiherr, J. et al. Intranasal insulin as a treatment for Alzheimer’s disease: a review of basic research and clinical evidence. CNS Drugs 27, 505–514, 10.1007/s40263-013-0076-8 (2013).
13. Benedict, C. et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29, 1326–1334, 10.1016/j.psyneuen.2004.04.003 (2004).
14. Craft, S. et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69, 29–38, 10.1001/archneurol.2011.233 (2012).
15. Lochhead, J. J. & Thorne, R. G. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64, 614–628, 10.1016/j.addr.2011.11.002 (2012).
16. Drejer, K. et al. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet Med 9, 335–340 (1992).
17. Salameh, T. S. et al. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition. J Alzheimers Dis 47, 715–728, 10.3233/JAD-150307 (2015).
18. Schmid, V. et al. Safety of intranasal human insulin: A review. Diabetes Obes Metab, 10.1111/dom.13279 (2018).
19. Nedelcovych, M. T. et al. Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse. ACS Chem Neurosci 9, 809–816, 10.1021/acschemneuro.7b00434 (2018).
20. Thorne, R. G., Pronk, G. J., Padmanabhan, V. & Frey, W. H. 2nd Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127, 481–496, 10.1016/j.neuroscience.2004.05.029 (2004).
21. Lochhead, J. J., Wolak, D. J., Pizzo, M. E. & Thorne, R. G. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metab 35, 371–381, 10.1038/jcbfm.2014.215 (2015).
22. Born, J. et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5, 514–516, 10.1038/nn849 (2002).
23. Rhea, E. M. et al. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition. J Alzheimers Dis 57, 241–252, 10.3233/JAD-161095 (2017).
24. Renner, D. B. et al. Intranasal delivery of insulin via the olfactory nerve pathway. J Pharm Pharmacol 64, 1709–1714, 10.1111/j.2042-7158.2012.01555.x (2012).
25. Spitzer, N., Sammons, G. S. & Price, E. M. Autofluorescent cells in rat brain can be convincing impostors in green fluorescent reporter studies. J Neurosci Methods 197, 48–55, 10.1016/j.jneumeth.2011.01.029 (2011).
26. Plum, L., Schubert, M. & Bruning, J. C. The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16, 59–65, 10.1016/j.tem.2005.01.008 (2005).
27. Tsuchiya, A., Kanno, T. & Nishizaki, T. Stearic acid serves as a potent inhibitor of protein tyrosine phosphatase 1B. Cell Physiol Biochem 32, 1451–1459, 10.1159/000356582 (2013).
28. Tsuchiya, A., Nagaya, H., Kanno, T. & Nishizaki, T. Oleic acid stimulates glucose uptake into adipocytes by enhancing insulin receptor signaling. J Pharmacol Sci 126, 337–343, 10.1254/jphs.14182FP (2014).
29. Carpenter, M. C. & Wilcox, D. E. Thermodynamics of formation of the insulin hexamer: metal-stabilized proton-coupled assembly of quaternary structure. Biochemistry 53, 1296–1301, 10.1021/bi4016567 (2014).
30. Hjorth, C. F. et al. Structure, Aggregation, and Activity of a Covalent Insulin Dimer Formed During Storage of Neutral Formulation of Human Insulin. J Pharm Sci 105, 1376–1386, 10.1016/j.xphs.2016.01.003 (2016).
31. Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7, 27–31, 10.4103/0976-0105.177703 (2016).
32. Banks, W. A., Jaspan, J. B. & Kastin, A. J. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18, 1257–1262 (1997).
33. Baskin, D. G. et al. Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes 35, 246–249 (1986).
34. Gray, S. M., Aylor, K. W. & Barrett, E. J. Unravelling the regulation of insulin transport across the brain endothelial cell. Diabetologia 60, 1512–1521, 10.1007/s00125-017-4285-4 (2017).
35. Hersom, M. et al. The insulin receptor is expressed and functional in cultured blood-brain barrier endothelial cells, but does not mediate insulin entry from blood-to-brain. Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00350.2016 (2018).
36. Konishi, M. et al. Endothelial insulin receptors differentially control insulin signaling kinetics in peripheral tissues and brain of mice. Proc Natl Acad Sci USA 114, E8478–E8487, 10.1073/pnas.1710625114 (2017).
37. Rhea, E. M., Rask-Madsen, C. & Banks, W. A. Insulin transport across the blood-brain barrier can occur independently of the insulin receptor. J Physiol 596, 4753–4765, 10.1113/JP276149 (2018).
38. Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4, 147ra111, 10.1126/scitranslmed.3003748 (2012).
39. Pizzo, M. E. et al. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery. J Physiol 596, 445–475, 10.1113/JP275105 (2018).
40. Banks, W. A., Owen, J. B. & Erickson, M. A. Insulin in the brain: there and back again. Pharmacol Ther 136, 82–93, 10.1016/j.pharmthera.2012.07.006 (2012).
41. Iliff, J. J. et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34, 16180–16193, 10.1523/JNEUROSCI.3020-14.2014 (2014).
42. Kress, B. T. et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 76, 845–861, 10.1002/ana.24271 (2014).
43. Peng, W. et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer’s disease. Neurobiol Dis 93, 215–225, 10.1016/j.nbd.2016.05.015 (2016).
44. Wang, M. et al. Focal Solute Trapping and Global Glymphatic Pathway Impairment in a Murine Model of Multiple Microinfarcts. J Neurosci 37, 2870–2877, 10.1523/JNEUROSCI.2112-16.2017 (2017).
45. Aldridge, G. M., Podrebarac, D. M., Greenough, W. T. & Weiler, I. J. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172, 250–254, 10.1016/j.jneumeth.2008.05.003 (2008).
46. Kirshner, Z. Z. & Gibbs, R. B. Use of the REVERT((R)) total protein stain as a loading control demonstrates significant benefits over the use of housekeeping proteins when analyzing brain homogenates by Western blot: An analysis of samples representing different gonadal hormone states. Mol Cell Endocrinol 473, 156–165, 10.1016/j.mce.2018.01.015 (2018).
47. Alexander-Bridges, M. et al. Multiple insulin-responsive elements regulate transcription of the GAPDH gene. Adv Enzyme Regul 32, 149–159 (1992).
48. McDaniel, M. L. et al. Temporal changes in islet polymerized and depolymerized tubulin during biphasic insulin release. Metabolism 29, 762–766 (1980).
49. Messina, J. L. & Weinstock, R. S. Regulation of beta-actin gene transcription by insulin and phorbol esters. Exp Cell Res 200, 532–535 (1992).
50. Tsakiridis, T. et al. Role of the actin cytoskeleton in insulin action. Microsc Res Tech 47, 79–92, 10.1002/(SICI)1097-0029(19991015)47:2 79::AID-JEMT1 3.0.CO;2-S (1999).
51. Wang, C., Li, Y., Wible, B., Angelides, K. J. & Ishii, D. N. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 13, 289–300 (1992).